open access

Vol 59, No 5 (2008)
Original papers
Published online: 2008-09-26
Submitted: 2013-02-15
Get Citation

The Polish version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) - four-stage translation and validation

Małgorzata Karbownik-Lewińska, Andrzej Lewiński, Stephen McKenna, Agnieszka Kokoszko, Sławomir Mucha, Jan Komorowski, Barbara Krzyżanowska-Świniarska, Maria Gryczyńska, Jerzy Sowiński, Roman Junik, David Meads, Maria Kołtowska-Häggström
Endokrynologia Polska 2008;59(5):374-384.

open access

Vol 59, No 5 (2008)
Original papers
Published online: 2008-09-26
Submitted: 2013-02-15

Abstract


Introduction: The Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) was developed simultaneously in five languages (English, Swedish, German, Italian and Spanish) to measure quality of life (QoL) in adult patients with Growth Hormone (GH) deficiency. The aim of the project was to produce a validated Polish version of the QoL-AGHDA that was conceptually equivalent to the UK-English version.
Material and methods: Translation and validation procedure consisted of 4 stages. Stage 1: A bilingual translation panel [7 participants, fluent in both English and Polish (Polish as their first language) with university education] translated the questionnaire. Stage 2: A lay translation panel (6 participants of an average to lower than average educational level, speaking only the target language) reviewed the wording of the draft version produced by bilingual panel to improve clarity and immediacy. Stage 3: The translated questionnaire was then field-tested with 15 adults with GH deficiency. Stage 4: Finally, the amended version underwent psychometric evaluation to check its reliability and validity (it was administered to 85 GH-deficient adults on two occasions, two weeks apart).
Results: The Polish QoL-AGHDA version was successfully adapted and it is characterized by a high degree of reliability and validity. The test-retest reliability coefficient for the Polish QoL-AGHDA was 0.92. The Cronbach’s Alpha coefficient for the Polish QoL-AGHDA was 0.91 (N = 70) at Time 1 and 0.94 (N = 79) at Time 2. Correlation between QoL-AGHDA and Nottingham Health Profile items confirmed high convergent and divergent validity.
Conclusions: The Polish QoL-AGHDA is a reliable and valid measure of QoL suitable for use in clinical studies and routine clinical practice. (Pol J Endocrinol 2008; 59 (5): 374-384)

Abstract


Introduction: The Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) was developed simultaneously in five languages (English, Swedish, German, Italian and Spanish) to measure quality of life (QoL) in adult patients with Growth Hormone (GH) deficiency. The aim of the project was to produce a validated Polish version of the QoL-AGHDA that was conceptually equivalent to the UK-English version.
Material and methods: Translation and validation procedure consisted of 4 stages. Stage 1: A bilingual translation panel [7 participants, fluent in both English and Polish (Polish as their first language) with university education] translated the questionnaire. Stage 2: A lay translation panel (6 participants of an average to lower than average educational level, speaking only the target language) reviewed the wording of the draft version produced by bilingual panel to improve clarity and immediacy. Stage 3: The translated questionnaire was then field-tested with 15 adults with GH deficiency. Stage 4: Finally, the amended version underwent psychometric evaluation to check its reliability and validity (it was administered to 85 GH-deficient adults on two occasions, two weeks apart).
Results: The Polish QoL-AGHDA version was successfully adapted and it is characterized by a high degree of reliability and validity. The test-retest reliability coefficient for the Polish QoL-AGHDA was 0.92. The Cronbach’s Alpha coefficient for the Polish QoL-AGHDA was 0.91 (N = 70) at Time 1 and 0.94 (N = 79) at Time 2. Correlation between QoL-AGHDA and Nottingham Health Profile items confirmed high convergent and divergent validity.
Conclusions: The Polish QoL-AGHDA is a reliable and valid measure of QoL suitable for use in clinical studies and routine clinical practice. (Pol J Endocrinol 2008; 59 (5): 374-384)
Get Citation

Keywords

QoL-AGHDA; quality of life; GH deficiency in adults; validation; Polish version

About this article
Title

The Polish version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) - four-stage translation and validation

Journal

Endokrynologia Polska

Issue

Vol 59, No 5 (2008)

Pages

374-384

Published online

2008-09-26

Bibliographic record

Endokrynologia Polska 2008;59(5):374-384.

Keywords

QoL-AGHDA
quality of life
GH deficiency in adults
validation
Polish version

Authors

Małgorzata Karbownik-Lewińska
Andrzej Lewiński
Stephen McKenna
Agnieszka Kokoszko
Sławomir Mucha
Jan Komorowski
Barbara Krzyżanowska-Świniarska
Maria Gryczyńska
Jerzy Sowiński
Roman Junik
David Meads
Maria Kołtowska-Häggström

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl